Message :
Required fields DIASORIN, IN PARTNERSHIP WITH QIAGEN, LAUNCHES THE NEW LIAISON® LYMEDETECT® ASSAY BASED ON QUANTIFERON TECHNOLOGY IN COUNTRIES ACCEPTING CE MARK FOR EARLY DIAGNOSIS OF LYME BORRELIOSIS THE LIAISON® LYMEDETECT® ASSAY IS A SOLUTION FOR THE EARLY DIAGNOSIS OF LYME BORRELIOSIS COMBINING DETECTION OF IGG AND IGM ANTIBODIES AND CELLULAR IMMUNITY THE TEST IS AVAILABLE IN COUNTRIES ACCEPTING THE CE MARK AND IS DESIGNED TO BE RUN ON
THE LIAISON® XL AND LIAISON® XS PLATFORMS IN CLINICAL STUDIES, THE ASSAY SHOWED, WITHIN 21 DAYS FROM THE FIRST EVIDENCE OF INFECTION, A SENSITIVITY OF 74% VERSUS THAT OF EXISTING ESTABLISHED METHODS AT 49%, WHILE ALSO DEMONSTRATING A HIGH DIAGNOSTIC SPECIFICITY OF 100%
QIAGEN N.V.: QIAGEN Launches artus Prep&Amp as CE-Marked SARS-CoV-2 Test Offering up to Threefold Increase in Daily Lab Testing Capacity
CE-IVD marking for Europe and other countries worldwide, EUA (Emergency Use Application) submission made in the U.S.
Streamlined workflow cuts costs and plastic usage offering time to result of about two hours
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the
artus SARS-CoV-2 Prep&Amp UM Kit which uses a liquid based sample preparation technology to simplify and increase COVID-19 testing throughput. The
artus SARS-CoV-2 Prep&Amp UM Kit has been CE-IVD registered for use in the European Union and other markets and an application for Emergency Use Authorization (EUA) has been submitted to the FDA, allowing commercialization via notification in the US.
QIAGEN N.V.: QIAGEN Adds to COVID-19 Portfolio With New Ultra-Fast Sequencing Solution for High-Throughput Genomic Surveillance
Kit supports analysis of over 6,000 samples simultaneously on highest-throughput sequencers
Integrates with QIAGEN Digital Insights cloud solutions to support variant detection and reporting including clade and lineage annotations across sequencing platforms
QIAGEN N.V. (NYSE:QGEN; Frankfurt Prime Standard:QIA) today announced the launch of QIAseq DIRECT SARS-CoV-2 Kit, a viral genome enrichment and library preparation solution that significantly reduces library turnaround times and plastics use compared with ARTIC project protocols (primer-based approaches for next-generation sequencing (NGS)). The lab and bioinformatic protocols of the ARTIC network, an initiative funded by the Wellcome Trust, are considered the gold standard in NGS-based characterization of SARS-CoV-2 genomes.
QIAGEN Adds to COVID-19 Portfolio With New Ultra-Fast Sequencing Solution for High-Throughput Genomic Surveillance apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.